Search research articles
Contact Us
Filters
Showing results (131-140 of 164) with videos related to
Page
of 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2017
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer
Cynthia X Ma, Feng Gao, Jingqin Luo, et al.
Nature Communications
|
September 19, 2018
Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer
Alex H Wagner, Siddhartha Devarakonda, Zachary L Skidmore, et al.
JCO Precision Oncology
|
April 20, 2023
Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2-Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates
Daniel A King, Amber R Smith, Gino Pineda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 7, 2017
A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III <i>PIK3CA</i>-Mutant ER-Positive and HER2-Negative Breast Cancer
Cynthia X Ma, Vera Suman, Matthew P Goetz, et al.
Genome Biology
|
August 11, 2010
Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors
Steven Jm Jones, Janessa Laskin, Yvonne Y Li, et al.
Nature Communications
|
September 6, 2018
The prognostic effects of somatic mutations in ER-positive breast cancer
Obi L Griffith, Nicholas C Spies, Meenakshi Anurag, et al.
Nature Communications
|
November 16, 2018
Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancer
Obi L Griffith, Nicholas C Spies, Meenakshi Anurag, et al.
Cancer Research Communications
|
November 1, 2023
Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma
Felicia Gomez, Bryan Fisk, Joshua F McMichael, et al.
Genome Medicine
|
November 14, 2024
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients
Xiuli Zhang, S Peter Goedegebuure, Michael Y Chen, et al.
Blood Advances
|
May 7, 2024
Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma
Cody A Ramirez, Michelle Becker-Hapak, Kartik Singhal, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 164) with videos related to
Sort By:
Page
of 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2017
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer
Cynthia X Ma, Feng Gao, Jingqin Luo, et al.
Nature Communications
|
September 19, 2018
Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer
Alex H Wagner, Siddhartha Devarakonda, Zachary L Skidmore, et al.
JCO Precision Oncology
|
April 20, 2023
Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2-Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates
Daniel A King, Amber R Smith, Gino Pineda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 7, 2017
A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III <i>PIK3CA</i>-Mutant ER-Positive and HER2-Negative Breast Cancer
Cynthia X Ma, Vera Suman, Matthew P Goetz, et al.
Genome Biology
|
August 11, 2010
Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors
Steven Jm Jones, Janessa Laskin, Yvonne Y Li, et al.
Nature Communications
|
September 6, 2018
The prognostic effects of somatic mutations in ER-positive breast cancer
Obi L Griffith, Nicholas C Spies, Meenakshi Anurag, et al.
Nature Communications
|
November 16, 2018
Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancer
Obi L Griffith, Nicholas C Spies, Meenakshi Anurag, et al.
Cancer Research Communications
|
November 1, 2023
Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma
Felicia Gomez, Bryan Fisk, Joshua F McMichael, et al.
Genome Medicine
|
November 14, 2024
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients
Xiuli Zhang, S Peter Goedegebuure, Michael Y Chen, et al.
Blood Advances
|
May 7, 2024
Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma
Cody A Ramirez, Michelle Becker-Hapak, Kartik Singhal, et al.
Page
of 17